These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 35563845)

  • 1. LINC00665: An Emerging Biomarker for Cancer Diagnostics and Therapeutics.
    Zhong C; Xie Z; Shen J; Jia Y; Duan S
    Cells; 2022 May; 11(9):. PubMed ID: 35563845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Micropeptide CIP2A-BP encoded by LINC00665 inhibits triple-negative breast cancer progression.
    Guo B; Wu S; Zhu X; Zhang L; Deng J; Li F; Wang Y; Zhang S; Wu R; Lu J; Zhou Y
    EMBO J; 2020 Jan; 39(1):e102190. PubMed ID: 31755573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MIR4435-2HG Is a Potential Pan-Cancer Biomarker for Diagnosis and Prognosis.
    Zhong C; Xie Z; Zeng LH; Yuan C; Duan S
    Front Immunol; 2022; 13():855078. PubMed ID: 35784328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LINC00665 induces gastric cancer progression through activating Wnt signaling pathway.
    Yang B; Bai Q; Chen H; Su K; Gao C
    J Cell Biochem; 2020 Mar; 121(3):2268-2276. PubMed ID: 31736127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LINC00665: A Promising Biomarker in Gastrointestinal Tumors.
    Yuan M; Gu Y; Chen J; Jiang Y; Qian J; Cao S
    Curr Mol Med; 2024; 24(1):51-59. PubMed ID: 36464865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Concise Review on Dysregulation of LINC00665 in Cancers.
    Ghafouri-Fard S; Khoshbakht T; Hussen BM; Baniahmad A; Taheri M; Hajiesmaeili M
    Cells; 2022 Nov; 11(22):. PubMed ID: 36429005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LINC00963: A potential cancer diagnostic and therapeutic target.
    Xie Z; Zhong C; Shen J; Jia Y; Duan S
    Biomed Pharmacother; 2022 Jun; 150():113019. PubMed ID: 35462329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LINC00665 promotes the viability, migration and invasion of T cell acute lymphoblastic leukemia cells by targeting miR-101 via modulating PI3K/Akt pathway.
    Abuduer M; A EZG
    Tissue Cell; 2021 Aug; 71():101579. PubMed ID: 34171521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of the Long Intergenic Non-Protein Coding RNA 665 (LINC00665) Gene and the Cell Cycle in Hepatocellular Carcinoma Using The Cancer Genome Atlas, the Gene Expression Omnibus, and Quantitative Real-Time Polymerase Chain Reaction.
    Wen DY; Lin P; Pang YY; Chen G; He Y; Dang YW; Yang H
    Med Sci Monit; 2018 May; 24():2786-2808. PubMed ID: 29728556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammation-Induced Long Intergenic Noncoding RNA (LINC00665) Increases Malignancy Through Activating the Double-Stranded RNA-Activated Protein Kinase/Nuclear Factor Kappa B Pathway in Hepatocellular Carcinoma.
    Ding J; Zhao J; Huan L; Liu Y; Qiao Y; Wang Z; Chen Z; Huang S; Zhao Y; He X
    Hepatology; 2020 Nov; 72(5):1666-1681. PubMed ID: 32083756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LINC00665 activates Wnt/β-catenin signaling pathway to facilitate tumor progression of colorectal cancer via upregulating CTNNB1.
    Han T; Gao M; Wang X; Li W; Zhuo J; Qu Z; Chen Y
    Exp Mol Pathol; 2021 Jun; 120():104639. PubMed ID: 33865827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of LINC00665 confers decreased cell proliferation and invasion via the miR-138-5p/E2F3 signaling pathway in NSCLC.
    Wang H; Wang L; Zhang S; Xu Z; Zhang G
    Biomed Pharmacother; 2020 Jul; 127():110214. PubMed ID: 32403047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Knockdown of LINC00665 inhibits proliferation and invasion of breast cancer via competitive binding of miR-3619-5p and inhibition of catenin beta 1.
    Lv M; Mao Q; Li J; Qiao J; Chen X; Luo S
    Cell Mol Biol Lett; 2020; 25():43. PubMed ID: 32983239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LINC00665 promotes cell proliferation, invasion, and metastasis by activating the TGF-β pathway in gastric cancer.
    Zhang X; Wu J
    Pathol Res Pract; 2021 Aug; 224():153492. PubMed ID: 34091388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LINC00665 sponges miR-641 to promote the progression of breast cancer by targeting the SNF2-related CREBBP activator protein (SRCAP).
    Cao W; Liu X; Su W; Liang H; Tang H; Zhang W; Huang S; Dang N; Qiao A
    Bioengineered; 2022 Feb; 13(2):4573-4586. PubMed ID: 35152838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging role of LINC00461 in cancer.
    Zhang Q; Zhong C; Shen J; Chen S; Jia Y; Duan S
    Biomed Pharmacother; 2022 Aug; 152():113239. PubMed ID: 35679722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Emerging Roles of LINC00665 in Human Cancers.
    Zhu J; Zhang Y; Chen X; Bian Y; Li J; Wang K
    Front Cell Dev Biol; 2022; 10():839177. PubMed ID: 35356290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism Analysis of LINC00665 and Its Peptides CIP2A-BP in Hepatocellular Carcinoma.
    Li YR; Zong RQ; Zhang HY; Meng XY; Wu FX
    Front Genet; 2022; 13():861096. PubMed ID: 35350239
    [No Abstract]   [Full Text] [Related]  

  • 19. LINC00665 promotes HeLa cell proliferation, migration, invasion and epithelial-mesenchymal transition by activating the WNT-CTNNB1/β‑catenin signaling pathway.
    Xia L; Chen YX; Lian JB
    Sheng Li Xue Bao; 2021 Apr; 73(2):233-243. PubMed ID: 33903885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Knockdown of long non-coding RNA HOTAIR inhibits cisplatin resistance of gastric cancer cells through inhibiting the PI3K/Akt and Wnt/β-catenin signaling pathways by up-regulating miR-34a.
    Cheng C; Qin Y; Zhi Q; Wang J; Qin C
    Int J Biol Macromol; 2018 Feb; 107(Pt B):2620-2629. PubMed ID: 29080815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.